MC5R and cancer: On August 4, 2022, Zhou and his colleagues published an intriguing article in Science, in which they elucidated a novel role of hypothalamic-pituitary-derived α-MSH and its activation of MC5R signaling in the regulation of myelopoiesis and immunosuppression in cancer-bearing murine models and human patients.3